Developing a new mRNA therapy or a small molecule drug comes with many challenges. One of the biggest is producing nanoparticles with consistent size. Inconsistent particle sizes can affect both the safety and effectiveness of a treatment. This is where polymer nanoparticles play a key role—they protect the drug and allow for precise delivery—but producing them reliably at scale has always been difficult.
Precision with High-Pressure Microfluidization
High-pressure microfluidization using a high-pressure homogenizer offers a solution. By forcing formulations through tiny microchannels at extremely high pressures, the process creates nanoparticles with precise size and shape. The result is stable, reproducible nanoformulations that work for a variety of therapeutic applications, including vaccines, protein therapies, and other drug delivery systems.
Scalable and Versatile
What makes this technology even more valuable is its scalability. Formulations developed in the lab can be scaled up to industrial production without losing uniformity. It works with polymer nanoparticles, liposomes, and lipid-based systems, helping optimize drug delivery, control release rates, and extend shelf life.
Streamlined Research and Development
For researchers, the process simplifies workflow. Adjusting formulations, testing parameters, and achieving consistent results becomes easier, making the transition from research and development to commercial production smooth and efficient.
Genizer high-pressure homogenizers deliver reliable, scalable microfluidization for both lab and industrial use, bridging the gap between innovation and real-world application.
Learn more about Genizer high-pressure homogenizers: https://www.genizer.com/nanogenizer_p0039.html
Sign in to leave a comment.